logo
T2

Exhibiting at Thaifex Anuga Asia, 2024

Hall: 7 Booth: 7-N43
IMPACT MUANG THONG THANI BANGKOK, THAILAND
28 May - 1 Jun, 2024

Product Offerings

Product Categories:

Anti-Cancer Drugs, Anti-Metabolic Syndrome Drugs

Products:

Mitochondrial-Based Treatments For Various Diseases, Nutrients, Other

Mitos Therapeutics Inc. is a biotech company based in central South Korea, specializing in the development of mitochondrial-based treatments for metabolic syndrome and cancer. Their focus is on fine-tuning energy metabolism to restore health, particularly in aging populations. They employ rigorous R&D to develop new treatments and ensure high-quality standards​ ((주)미토스테라퓨틱스 - 의약전문 벤처기업)​​ ((주)미토스테라퓨틱스 - 의약전문 벤처기업)​​ ((주)미토스테라퓨틱스 - 의약전문 벤처기업)​. Target Market: China, South East Asia, USA Sales Channel: Department Store, Hotel & Resort, Importer, Online Shop, Wholesaler Specialisation: Functional & Free-From Products